Prevalencia y factores asociados a la automedicación de antibióticos en cadenas de farmacia en tiempo de COVID-19. Lima -2021
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Universidad Privada de Huancayo Franklin Roosevelt
DOI
Abstract
El trabajo de investigación tuvo como OBJETIVO principal identificar la prevalencia y los factores asociados a la automedicación de antibióticos en cadenas de farmacia en tiempo de COVID-19 – Los olivos-Lima. MÉTODOLOGIA: Cuantitativo, nivel básico, diseño no experimental, transversal, CONCLUYÉNDOSE: La prevalencia de la automedicación, fue la frecuencia de consumo de los antibióticos donde se realiza una vez por día por 7 días y los riesgos de consumo de antibióticos que se encontraron fue la diarrea, vómitos, dolor abdominal, cansancio, debilidad, visión borrosa y dolor
The main OBJECTIVE of the research work was to identify the prevalence and factors associated with the self-medication of antibiotics in chain pharmacies in COVID-19 - Los Olivos-Lima. METHODOLOGY: Quantitative, basic level, non-experimental, cross-sectional design, CONCLUDING: The prevalence of self-medication, was the frequency of consumption of antibiotics where it is done once a day for 7 days and the risks of antibiotic consumption that were found were diarrhea, vomiting, abdominal pain, fatigue, weakness, blurred vision and pain
The main OBJECTIVE of the research work was to identify the prevalence and factors associated with the self-medication of antibiotics in chain pharmacies in COVID-19 - Los Olivos-Lima. METHODOLOGY: Quantitative, basic level, non-experimental, cross-sectional design, CONCLUDING: The prevalence of self-medication, was the frequency of consumption of antibiotics where it is done once a day for 7 days and the risks of antibiotic consumption that were found were diarrhea, vomiting, abdominal pain, fatigue, weakness, blurred vision and pain
Description
Keywords
Citation
Vancouver
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as info:eu-repo/semantics/openAccess
